Cargando…
The impact of pulmonary arterial hypertension-targeted therapy on survival in Chinese patients with idiopathic pulmonary arterial hypertension
The survival rates of Chinese patients with idiopathic pulmonary arterial hypertension (IPAH) and familial pulmonary arterial hypertension (PAH) on conventional therapy at 1 and 3 years were 68.0% and 38.9%, respectively. Our aim was to update recent knowledge on the demographics, clinical course, h...
Autores principales: | Zeng, Wei-Jie, Sun, Yun-Juan, Gu, Qing, Xiong, Chang-Ming, Li, Jian-Jun, He, Jian-Guo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3487306/ https://www.ncbi.nlm.nih.gov/pubmed/23130106 http://dx.doi.org/10.4103/2045-8932.101655 |
Ejemplares similares
-
Potential biomarkers and therapeutic targets of idiopathic pulmonary arterial hypertension
por: He, Wenjun, et al.
Publicado: (2022) -
Comparison of 18F-FDG uptake by right ventricular myocardium in idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with congenital heart disease
por: Fang, Wei, et al.
Publicado: (2012) -
Idiopathic Pulmonary Arterial Hypertension and Pulmonary Arterial Hypertension Associated With Congenital Heart Disease in Chinese Children: Similarities, Differences, and Prognostic Factors
por: Gu, Li, et al.
Publicado: (2020) -
Pulmonary venous remodeling in COPD-pulmonary hypertension and idiopathic pulmonary arterial hypertension
por: Andersen, Kasper Hasseriis, et al.
Publicado: (2017) -
Impact of right ventricular dyssynchrony on prognosis of patients with idiopathic pulmonary arterial hypertension
por: Cheng, Xiao-Ling, et al.
Publicado: (2019)